The development of monoclonal antibodies (mAbs) has paved the way for innovative treatments in oncology and autoimmune diseases. With the mAb therapeutic market expected to reach $300 billion by 2025, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results